Congress Receives FDA’s User Fee Reauthorization Recommendations
The HHS secretary recently delivered FDA’s recommendations for reauthorizing user fees covering prescriptions, generic drugs and biosimilars to Congress, before the body begins to craft a legislation package due by the end of September.
Source: Drug Industry Daily